Radiation-controlled focal pharmacology in the therapy of experimental epilepsy

M. P. Remler, W. Marcussen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Radiation-controlled focal pharmacology is a method using intermediate-dose radiation of a portion of the brain to break down the blood-brain barrier (BBB) followed by the administration of a drug which does not cross the normal BBB but which has a desired pharmacologic effect when it does cross the BBB. Therefore, the drug affects only the radiated portion of the brain. Cats with alumina-cobalt chronic epileptic foci were given intravenous γ-aminobutyric acid (GABA) with no suppression of their EEG-recorded, computer-analyzed epileptic spike frequency. When the focus received 6,000 rad of Bragg peak proton radiation, there was no significant change in spike frequency. Then, however, when GABA was again given, there was dramatic suppression of spike frequency, reaching a peak of 87% suppression at 9 days postradiation. The efficacy of GABA used in radiation-controlled focal pharmacology in the 7- to 9-day postradiation period was demonstrated with a confidence of p < 0.01.

Original languageEnglish (US)
Pages (from-to)153-159
Number of pages7
JournalEpilepsia
Volume22
Issue number2
StatePublished - 1981

Fingerprint

Investigational Therapies
Aminobutyrates
Epilepsy
Blood-Brain Barrier
Pharmacology
Radiation
Aluminum Oxide
Brain
Cobalt
Pharmaceutical Preparations
Protons
Electroencephalography
Cats

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Remler, M. P., & Marcussen, W. (1981). Radiation-controlled focal pharmacology in the therapy of experimental epilepsy. Epilepsia, 22(2), 153-159.

Radiation-controlled focal pharmacology in the therapy of experimental epilepsy. / Remler, M. P.; Marcussen, W.

In: Epilepsia, Vol. 22, No. 2, 1981, p. 153-159.

Research output: Contribution to journalArticle

Remler, MP & Marcussen, W 1981, 'Radiation-controlled focal pharmacology in the therapy of experimental epilepsy', Epilepsia, vol. 22, no. 2, pp. 153-159.
Remler, M. P. ; Marcussen, W. / Radiation-controlled focal pharmacology in the therapy of experimental epilepsy. In: Epilepsia. 1981 ; Vol. 22, No. 2. pp. 153-159.
@article{2cabc3b16d3f4662b7af39cf39c0b6e9,
title = "Radiation-controlled focal pharmacology in the therapy of experimental epilepsy",
abstract = "Radiation-controlled focal pharmacology is a method using intermediate-dose radiation of a portion of the brain to break down the blood-brain barrier (BBB) followed by the administration of a drug which does not cross the normal BBB but which has a desired pharmacologic effect when it does cross the BBB. Therefore, the drug affects only the radiated portion of the brain. Cats with alumina-cobalt chronic epileptic foci were given intravenous γ-aminobutyric acid (GABA) with no suppression of their EEG-recorded, computer-analyzed epileptic spike frequency. When the focus received 6,000 rad of Bragg peak proton radiation, there was no significant change in spike frequency. Then, however, when GABA was again given, there was dramatic suppression of spike frequency, reaching a peak of 87{\%} suppression at 9 days postradiation. The efficacy of GABA used in radiation-controlled focal pharmacology in the 7- to 9-day postradiation period was demonstrated with a confidence of p < 0.01.",
author = "Remler, {M. P.} and W. Marcussen",
year = "1981",
language = "English (US)",
volume = "22",
pages = "153--159",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Radiation-controlled focal pharmacology in the therapy of experimental epilepsy

AU - Remler, M. P.

AU - Marcussen, W.

PY - 1981

Y1 - 1981

N2 - Radiation-controlled focal pharmacology is a method using intermediate-dose radiation of a portion of the brain to break down the blood-brain barrier (BBB) followed by the administration of a drug which does not cross the normal BBB but which has a desired pharmacologic effect when it does cross the BBB. Therefore, the drug affects only the radiated portion of the brain. Cats with alumina-cobalt chronic epileptic foci were given intravenous γ-aminobutyric acid (GABA) with no suppression of their EEG-recorded, computer-analyzed epileptic spike frequency. When the focus received 6,000 rad of Bragg peak proton radiation, there was no significant change in spike frequency. Then, however, when GABA was again given, there was dramatic suppression of spike frequency, reaching a peak of 87% suppression at 9 days postradiation. The efficacy of GABA used in radiation-controlled focal pharmacology in the 7- to 9-day postradiation period was demonstrated with a confidence of p < 0.01.

AB - Radiation-controlled focal pharmacology is a method using intermediate-dose radiation of a portion of the brain to break down the blood-brain barrier (BBB) followed by the administration of a drug which does not cross the normal BBB but which has a desired pharmacologic effect when it does cross the BBB. Therefore, the drug affects only the radiated portion of the brain. Cats with alumina-cobalt chronic epileptic foci were given intravenous γ-aminobutyric acid (GABA) with no suppression of their EEG-recorded, computer-analyzed epileptic spike frequency. When the focus received 6,000 rad of Bragg peak proton radiation, there was no significant change in spike frequency. Then, however, when GABA was again given, there was dramatic suppression of spike frequency, reaching a peak of 87% suppression at 9 days postradiation. The efficacy of GABA used in radiation-controlled focal pharmacology in the 7- to 9-day postradiation period was demonstrated with a confidence of p < 0.01.

UR - http://www.scopus.com/inward/record.url?scp=0019512705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019512705&partnerID=8YFLogxK

M3 - Article

C2 - 6781892

AN - SCOPUS:0019512705

VL - 22

SP - 153

EP - 159

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 2

ER -